You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 55 No. 12, December 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters to the Editor
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Limitations of Acetaminophen, Aspirin, and Caffeine in Alleviating Migraine

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The conclusions of Lipton et al1 that the combination of aspirin, acetaminophen, and caffeine was highly effective for the treatment of migraine headache symptoms requires further comment. They acknowledge in their "Patients and Methods" section that the most severely disabled segment of migraineurs was excluded. However, they do not tell us what percentage of the potential population was excluded for this reason. In a previous article2 by the first 2 authors of the current study, severe disability was identified in 50% of migraineurs who had been diagnosed by a physician and 25% of migraineurs who had not been previously diagnosed.

The lack of relapse data is surprising in any study of an acute headache treatment and is a major limitation of this study.

I would suggest the conclusion should be limited to say that, for migraineurs who are not usually severely disabled, the combination of aspirin, acetaminophen, and caffeine produces . . . [Full Text of this Article]



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Efficacy and Safety of Acetaminophen in the Treatment of Migraine: Results of a Randomized, Double-blind, Placebo-Controlled, Population-Based Study
Lipton et al.
Arch Intern Med 2000;160:3486-3492.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.